Literature DB >> 8157157

Autism in thalidomide embryopathy: a population study.

K Strömland1, V Nordin, M Miller, B Akerström, C Gillberg.   

Abstract

Of a population of 100 Swedish thalidomide embryopathy cases, at least four met full criteria for DSM-III-R autistic disorder and ICD-10 childhood autism. Thalidomide embryopathy of the kind encountered in these cases affects fetal development early in pregnancy, probably on days 20 to 24 after conception. It is argued that the possible association of thalidomide embryopathy with autism may shed some light on the issue of which neural circuitries may be involved in autism pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157157     DOI: 10.1111/j.1469-8749.1994.tb11856.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  81 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort.

Authors:  Jason I Feinberg; Kelly M Bakulski; Andrew E Jaffe; Rakel Tryggvadottir; Shannon C Brown; Lynn R Goldman; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; M Daniele Fallin; Andrew P Feinberg
Journal:  Int J Epidemiol       Date:  2015-04-14       Impact factor: 7.196

3.  Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.

Authors:  Tania Rinaldi; Karina Kulangara; Katia Antoniello; Henry Markram
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

4.  Timing of prenatal stressors and autism.

Authors:  D Q Beversdorf; S E Manning; A Hillier; S L Anderson; R E Nordgren; S E Walters; H N Nagaraja; W C Cooley; S E Gaelic; M L Bauman
Journal:  J Autism Dev Disord       Date:  2005-08

5.  Multiple autism-like behaviors in a novel transgenic mouse model.

Authors:  Shannon M Hamilton; Corinne M Spencer; Wilbur R Harrison; Lisa A Yuva-Paylor; Deanna F Graham; Ray A M Daza; Robert F Hevner; Paul A Overbeek; Richard Paylor
Journal:  Behav Brain Res       Date:  2010-11-17       Impact factor: 3.332

6.  Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): An aquatic model for autism.

Authors:  Jiangfei Chen; Lei Lei; Linjie Tian; Fei Hou; Courtney Roper; Xiaoqing Ge; Yuxin Zhao; Yuanhong Chen; Qiaoxiang Dong; Robert L Tanguay; Changjiang Huang
Journal:  Neurotoxicol Teratol       Date:  2018-01-05       Impact factor: 3.763

Review 7.  Genetics of autism: overview and new directions.

Authors:  P Szatmari; M B Jones; L Zwaigenbaum; J E MacLean
Journal:  J Autism Dev Disord       Date:  1998-10

8.  Autism with ophthalmologic malformations: the plot thickens.

Authors:  Marilyn T Miller; Kerstin Strömland; Liana Ventura; Maria Johansson; Jose M Bandim; Christopher Gillberg
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  The minicolumnopathy of autism: A link between migraine and gastrointestinal symptoms.

Authors:  Manuel F Casanova
Journal:  Med Hypotheses       Date:  2007-06-14       Impact factor: 1.538

10.  Brainstem volumetric alterations in children with autism.

Authors:  R J Jou; N J Minshew; N M Melhem; M S Keshavan; A Y Hardan
Journal:  Psychol Med       Date:  2008-09-24       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.